V
Valeo Pharma
Valeo Pharma Inc is committed to provide healthcare professionals and patients with therapeutic solutions
About Valeo Pharma
Valeo Pharma, founded in 2003, is a specialty pharmaceutical company based in Canada. The company focuses on licensing and acquiring Canadian rights to commercial-stage, innovative, and proprietary drugs. Valeo Pharma's portfolio includes nine commercialized products primarily in the therapeutic areas of Ophthalmology and Specialty Products. The company serves healthcare professionals and patients by providing advanced therapeutic solutions aimed at improving quality of life. Operating in the Canadian healthcare market, Valeo Pharma's business model revolves around acquiring rights to innovative drugs and bringing them to the Canadian market. Revenue is generated through the commercialization of these licensed and proprietary drugs. The company has a strong leadership team with extensive experience in the pharmaceutical industry, ensuring the successful development and growth of its product portfolio.
Source: Dealroom company dataAt a glance
- Status
- Listed
- Founded
- 2003
- Headquarters
- Montreal, Canada
- Listing
- IPO 2019
- Sector
- Biotech & Life Sciences
- Power Law
- Colt$25–100M revenue
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later2 investors entered at this stage
Sagard
Accord Financial
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Valeo Pharma on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Valeo Pharma on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.